Exploring the variability in acute glycemic responses to exercise in type 2 diabetes

Tasuku Terada, Alanna Friesen, Baljot S Chahal, Gordon J Bell, Linda J McCargar, Normand G Boulé, Tasuku Terada, Alanna Friesen, Baljot S Chahal, Gordon J Bell, Linda J McCargar, Normand G Boulé

Abstract

Aim: To explore the factors associated with exercise-induced acute capillary glucose (CapBG) changes in individuals with type 2 diabetes (T2D).

Methods: Fifteen individuals with T2D were randomly assigned to energy-matched high intensity interval exercise (HI-IE) and moderate intensity continuous exercise (MI-CE) interventions and performed a designated exercise protocol 5 days per week for 12 weeks. The duration of exercise progressed from 30 to 60 minutes. CapBG was measured immediately before and after each exercise session. Timing of food and antihyperglycemic medication intake prior to exercise was recorded.

Results: Overall, the mean CapBG was lowered by 1.9 mmol/L (P < 0.001) with the change ranging from -8.9 to +2.7 mmol/L. Preexercise CapBG (44%; P < 0.001), medication (5%; P < 0.001), food intake (4%; P = 0.043), exercise duration (5%; P < 0.001), and exercise intensity (1%; P = 0.007) were all associated with CapBG changes, explaining 59% of the variability.

Conclusion: The greater reduction in CapBG seen in individuals with higher preexercise CapBG may suggest the importance of exercise in the population with elevated glycemia. Lower blood glucose can be achieved with moderate intensity exercise, but prolonging exercise duration and/or including brief bouts of intense exercise accentuate the reduction, which can further be magnified by performing exercise after meals and antihyperglycemic medication. This trial is registered with ClinicalTrial.gov NCT01144078.

Figures

Figure 1
Figure 1
Effects of exercise intervention, exercise duration, exercise modality, food intake, and medication on exercise-induced CapBG reduction. Values are least square mean ± SE. *HI-IE (P = 0.007), †45 min exercise (P = 0.015), ‡60 min exercise (P < 0.001), §food intake <2 hours (P = 0.043), and ψmedication ≤6 hours of exercise (P < 0.001) were all associated with greater CapBG reduction. HI-IE: high intensity interval exercise; MI-CE: moderate intensity continuous exercise; CapBG: capillary blood glucose.
Figure 2
Figure 2
Correlations between preexercise CapBG and exercise-induced CapBG changes for both HI-IE and MI-CE. Filled and open squares represent MI-CE and HI-IE, respectively. Dotted and straight lines are regression lines of MI-CE and HI-IE, respectively. Glucose data obtained from each participant are categorized based on exercise intensity, duration, and modality, as well as food and medication status. Each box in the figure represents the mean glucose value obtained from each participant under different conditions. HI-IE: high intensity interval exercise; MI-CE: moderate intensity continuous exercise; CapBG: capillary blood glucose.

References

    1. Umpierre D, Ribeiro PAB, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association. 2011;305(17):1790–1799.
    1. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006;29(11):2518–2527.
    1. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. Journal of the American Medical Association. 2001;286(10):1218–1227.
    1. Umpierre D, Ribeiro PA, Schaan BD, Ribeiro JP. Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia. 2012;56:242–251.
    1. Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia. 2003;46(8):1071–1081.
    1. Duclos M, Virally M-L, Dejager S. Exercise in the management of type 2 diabetes mellitus: what are the benefits and how does it work? Physician and Sportsmedicine. 2011;39(2):98–106.
    1. Jeng C, Chang W-Y, Chen S-R, Tseng I-J. Effects of arm exercise on serum glucose response in type 2 DM patients. The Journal of Nursing Research. 2002;10(3):187–194.
    1. Jeng C, Ku C-T, Huang W-H. Establishment of a predictive model of serum glucose changes under different exercise intensities and durations among patients with type 2 diabetes mellitus. The Journal of Nursing Research. 2003;11(4):287–294.
    1. Hiyane WC, de Sousa MV, Moreira S, et al. Blood glucose responses of Type-2 diabetics during and after exercise performed at intensities above and below anaerobic threshold. Brazilian. Journal of Kineanthropometry and Human Performance. 2008;10:8–11.
    1. Kjaer M, Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W, Reaven GM. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. Journal of Applied Physiology. 1990;68(5):2067–2074.
    1. Kang J, Kelley DE, Robertson RJ, et al. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Medicine and Science in Sports and Exercise. 1999;31(1):82–89.
    1. Larsen JJS, Dela F, Madsbad S, Galbo H. The effect of intense exercise on postprandial glucose homeostasis in Type II diabetic patients. Diabetologia. 1999;42(11):1282–1292.
    1. Poirier P, Tremblay A, Catellier C, Tancrède G, Garneau C, Nadeau A. Impact of time interval from the last meal on glucose response to exercise in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism. 2000;85(8):2860–2864.
    1. Boulé NG, Robert C, Bell GJ, et al. Metformin and exercise in type 2 diabetes: examining treatment modality interactions. Diabetes Care. 2011;34(7):1469–1474.
    1. Terada T, Friesen A, Chahal S, Bell J, McCargar L, Boulé N. Feasibility and preliminary efficacy of high intensity interval training in type 2 diabetes. Diabetes Research and Clinical Practice. 2013;99(2):120–129.
    1. American College of Sports Medicine. ACSM's Guidelines for Graded Exercise Testing and Prescription. 8th edition. Philadelphia, Pa, USA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010.
    1. Brunner GA, Ellmerer M, Sendlhofer G, et al. Validation of home blood glucose meters respect to clinical and analytical approaches. Diabetes Care. 1998;21(4):585–590.
    1. Larsen JJS, Dela F, Kjær M, Galbo H. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia. 1997;40(4):447–453.
    1. Montain SJ, Hopper MK, Coggan AR, Coyle EF. Exercise metabolism at different time intervals after a meal. Journal of Applied Physiology. 1991;70(2):882–888.
    1. U.S. Food and Drug Administration. Glucophage [metformin hydrochloride tablets] information. 2008, .
    1. Karstoft K, Winding K, Knudsen SH, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in Type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2013;36:228–236.
    1. Tjønna AE, Lee SJ, Rognmo Ø, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118(4):346–354.
    1. Gaudet-Savard T, Ferland A, Broderick TL, et al. Safety and magnitude of changes in blood glucose levels following exercise performed in the fasted and the postprandial state in men with type 2 diabetes. European Journal of Cardiovascular Prevention and Rehabilitation. 2007;14(6):831–836.
    1. Ceriello A, Hanefeld M, Leiter L, et al. Postprandial glucose regulation and diabetic complications. Archives of Internal Medicine. 2004;164(19):2090–2095.
    1. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Journal of the American Medical Association. 2006;295(14):1681–1687.
    1. Gudat U, Bungert S, Kemmer F, Heinemann L. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus. Diabetic Medicine. 1998;15:194–198.
    1. Larsen JJ, Dela F, Madsbad S, Vibe-Petersen J, Galbo H. Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients. Diabetes Care. 1999;22(10):1647–1654.
    1. Massi-Benedetti M, Herz M, Pfeiffer C. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or clibenclamide. Hormone and Metabolic Research. 1996;28(9):451–455.
    1. Sharoff CG, Hagobian TA, Malin SK, et al. Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. American Journal of Physiology—Endocrinology and Metabolism. 2010;298(4):E815–E823.

Source: PubMed

3
Subscribe